Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 93

Sort by

Sort Order Select

Journal Articles

Poor neutrophil recovery following CD19-targeted CAR-T cell therapy predicts inferior outcomes in adult patients with B-cell lymphoma

Hiroaki Shimizu, Satoshi Koi, Shuhei Kurosawa, Yu Yagi, Daichi Sadato, Fumihiko Ouchi, Masashi Shimabukuro, Atsushi Jinguji, Yusuke Kanemasa, Kaoru Morita, Takashi Toya, Yuho Najima, Tomomi Toubai, Yuka Harada, Tatsu Shimoyama, Kyoko Haraguchi, Noriko Doki

Blood (2025) 146 (Supplement 1): 5496.

https://doi.org/10.1182/blood-2025-5496

Published: 2025

Journal Articles

Maintenance treatment with gilteritinib suppresses post-transplant relapse in relapsed/refractory FLT3-mutated acute myeloid leukemia: A Japanese nationwide registry study

Blood (2025) 146 (Supplement 1): 4289.

https://doi.org/10.1182/blood-2025-4289

Published: 2025

Journal Articles

Serum albumin, but not gnri, is an independent prognostic factor for survival after first allogeneic SCT: A large-scale multicenter analysis

Blood (2025) 146 (Supplement 1): 2513.

https://doi.org/10.1182/blood-2025-2513

Published: 2025

Journal Articles

TP53, EZH2, or RUNX1 mutations predict poor outcomes in ELN 2022 adverse risk group of adult AML patients undergoing allo-HSCT

Blood (2025) 146 (Supplement 1): 2522.

https://doi.org/10.1182/blood-2025-2522

Published: 2025

Journal Articles

Five-year interim analysis of multi-institutional collaborative study for estimating the persistence of treatment free remission in chronic myeloid leukemia after stopping tyrosine kinase inhibitor in Japan: J-SKI

Blood (2025) 146 (Supplement 1): 5545.

https://doi.org/10.1182/blood-2025-5545

Published: 2025

Journal Articles

Development and evaluation of a protein language model-based prediction model for acute graft-versus-host disease in HLA-mismatched hematopoietic stem cell transplantation

Makoto Moriguchi, Soichiro Nakako, Hiroshi Okamura, Takakazu Kawase, Kyoko Fuse, Toshiki Terao, Kazuki Yoshimura, Noriko Doki, Takahiro Fukuda, Yuta Katayama, Tetsuya Eto, Kentaro Serizawa, Makoto Onizuka, Makoto Yoshimitsu, Yoshinobu Kanda, Ken Tabuchi, Yoshiko Atsuta, Junya Kanda, Makoto Murata

Blood (2025) 146 (Supplement 1): 4222.

https://doi.org/10.1182/blood-2025-4222

Published: 2025

Journal Articles

Differential trends in survival after allogeneic transplantation for MDS and MDS/MPN in a real-world experience

Blood (2025) 146 (Supplement 1): 3843.

https://doi.org/10.1182/blood-2025-3843

Published: 2025

Journal Articles

Nelarabine treatment before allogeneic stem cell transplantation was associated with an increased risk of neurological adverse events in patients with T-ALL/lbl: A retrospective study of the kanto study group for cell therapy.

Blood (2025) 146 (Supplement 1): 6043.

https://doi.org/10.1182/blood-2025-6043

Published: 2025

Journal Articles

Phase 1 evaluation of the safety and efficacy of rapcabtagene autoleucel (YTB323) in adult patients with Relapsed/Refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)

Blood (2025) 146 (Supplement 1): 811.

https://doi.org/10.1182/blood-2025-811

Published: 2025

Journal Articles

To What Extent Have Post-Transplant Outcomes Improved Following the Introduction of Tyrosine Kinase Inhibitors in Elderly Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia? a Retrospective Nationwide Survey in Japan

Shuichi Mizuta, Tomotaka Ugai, Satoshi Nishiwaki, Noriko Doki, Takahiro Fukuda, Tetsuya Nishida, Yuta Katayama, Shuichi Ota, Yuta Hasegawa, Masatsugu Tanaka, Makoto Onizuka, Tatsuo Ichinohe, Koji Kawamura, Yoshiko Atsuta, Yasuyuki Arai

Blood (2024) 144 (Supplement 1): 3569.

https://doi.org/10.1182/blood-2024-201434

Published: 2024

Journal Articles

JALSG Ph (-) B-ALL213 Study: Pediatric-Type Chemotherapy Improves Prognosis in Adult Ph-Negative Acute Lymphoblastic Leukemia Patients, Including Older Adults

Blood (2024) 144 (Supplement 1): 2819.

https://doi.org/10.1182/blood-2024-199435

Published: 2024

Journal Articles

Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia with t(16;21)(p11;q22)

Satoshi Mitsuyuki, Yoshimitsu Shimomura, Hiroki Mizumaki, Masamitsu Yanada, Shohei Mizuno, Naoyuki Uchida, Noriko Doki, Ayumu Ito, Masatsugu Tanaka, Tetsuya Nishida, Yuta Katayama, Satoshi Yoshihara, Tetsuya Eto, Koji Kawamura, Makoto Onizuka, Takahiro Fukuda, Marie Ohbiki, Yoshiko Atsuta, Takaaki Konuma

Blood (2024) 144 (Supplement 1): 1469.

https://doi.org/10.1182/blood-2024-198750

Published: 2024

Journal Articles

Kinetics of Recipients with Thrombocytopenia and Its Impact on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Retrospective Study

Blood (2024) 144 (Supplement 1): 2121.

https://doi.org/10.1182/blood-2024-201927

Published: 2024

Journal Articles

Treatment Outcomes of Adult Patients with B-Cell Acute Lymphoblastic Leukemia Relapsed after Allogeneic Stem Cell Transplant in the Era of Novel Immunochemotherapeutic Agents

Blood (2024) 144 (Supplement 1): 3541.

https://doi.org/10.1182/blood-2024-199077

Published: 2024

Journal Articles

Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGIC

Blood (2024) 144 (Supplement 1): 384.

https://doi.org/10.1182/blood-2024-203344

Published: 2024

Journal Articles

Novel Method to Evaluate the Quantitative Immune Functionality of CAR T-Cells to Analyze the Localization Change of CAR Molecules

Hiroshi Yasui, Keiji Hirano, Asako Kobayashi, Lihua Li, Takuya Takahashi, Margarita Artemenko, Naotaka Noda, Daichi Sadato, Kyoko Haraguchi, Ayako Arai, Kohzoh Imai, Noriko Doki, Masatoshi Yanagida, Tomohiro Ishigaki

Blood (2024) 144 (Supplement 1): 4851.

https://doi.org/10.1182/blood-2024-198277

Published: 2024

Journal Articles

Prognostic Impact of Graft-Versus-Host Disease on Allogeneic Transplantation for CMML Focusing on Conditioning Intensity

Hidehiro Itonaga, Yasushi Miyazaki, Machiko Fujioka, Shuhei Kurosawa, Yasunobu Nagata, Yutaka Shimazu, Tomoaki Ueda, Naoyuki Uchida, Noriko Doki, Tetsuya Nishida, Ken-ichi Matsuoka, Masatsugu Tanaka, Makoto Yoshimitsu, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Takayoshi Tachibana

Blood (2024) 144 (Supplement 1): 6755.

https://doi.org/10.1182/blood-2024-193699

Published: 2024

Journal Articles

Frequent Loss of HLA-B*40:02 from Leukocytes in Male Patients with Hepatitis-Associated Aplastic Anemia

Blood (2024) 144 (Supplement 1): 1311.

https://doi.org/10.1182/blood-2024-197892

Published: 2024

Journal Articles

Identifying the Optimal Conditioning Intensity of Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in Complete Remission

Blood (2023) 142 (Supplement 1): 2150.

https://doi.org/10.1182/blood-2023-181621

Published: 2023

Journal Articles

Immune Function of Chimeric Antigen Receptor T Cells Quantitatively Assessed Via Molecular Imaging Flow Cytometry

Hiroshi Yasui, Kenji Hirano, Kiyosumi Ochi, Asako Kobayashi, Lihua Li, Daichi Sadato, Noriko Doki, Masatoshi Yanagida, Tomohiro Ishigaki

Blood (2023) 142 (Supplement 1): 6821.

https://doi.org/10.1182/blood-2023-173065

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Poor neutrophil recovery following CD19-targeted CAR-T cell therapy predicts inferior outcomes in adult patients with B-cell lymphoma

Maintenance treatment with gilteritinib suppresses post-transplant relapse in relapsed/refractory FLT3-mutated acute myeloid leukemia: A Japanese nationwide registry study

Serum albumin, but not gnri, is an independent prognostic factor for survival after first allogeneic SCT: A large-scale multicenter analysis

TP53, EZH2, or RUNX1 mutations predict poor outcomes in ELN 2022 adverse risk group of adult AML patients undergoing allo-HSCT

Five-year interim analysis of multi-institutional collaborative study for estimating the persistence of treatment free remission in chronic myeloid leukemia after stopping tyrosine kinase inhibitor in Japan: J-SKI

Development and evaluation of a protein language model-based prediction model for acute graft-versus-host disease in HLA-mismatched hematopoietic stem cell transplantation

Differential trends in survival after allogeneic transplantation for MDS and MDS/MPN in a real-world experience

Nelarabine treatment before allogeneic stem cell transplantation was associated with an increased risk of neurological adverse events in patients with T-ALL/lbl: A retrospective study of the kanto study group for cell therapy.

Phase 1 evaluation of the safety and efficacy of rapcabtagene autoleucel (YTB323) in adult patients with Relapsed/Refractory B-cell acute lymphoblastic leukemia (r/r B-ALL)

To What Extent Have Post-Transplant Outcomes Improved Following the Introduction of Tyrosine Kinase Inhibitors in Elderly Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia? a Retrospective Nationwide Survey in Japan

JALSG Ph (-) B-ALL213 Study: Pediatric-Type Chemotherapy Improves Prognosis in Adult Ph-Negative Acute Lymphoblastic Leukemia Patients, Including Older Adults

Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia with t(16;21)(p11;q22)

Kinetics of Recipients with Thrombocytopenia and Its Impact on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Retrospective Study

Treatment Outcomes of Adult Patients with B-Cell Acute Lymphoblastic Leukemia Relapsed after Allogeneic Stem Cell Transplant in the Era of Novel Immunochemotherapeutic Agents

Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGIC

Novel Method to Evaluate the Quantitative Immune Functionality of CAR T-Cells to Analyze the Localization Change of CAR Molecules

Prognostic Impact of Graft-Versus-Host Disease on Allogeneic Transplantation for CMML Focusing on Conditioning Intensity

Frequent Loss of HLA-B*40:02 from Leukocytes in Male Patients with Hepatitis-Associated Aplastic Anemia

Identifying the Optimal Conditioning Intensity of Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in Complete Remission

Immune Function of Chimeric Antigen Receptor T Cells Quantitatively Assessed Via Molecular Imaging Flow Cytometry

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only